Hub : Traits :

Current tobacco smoking

58 significantly associated models · 37 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 7 116660803 118207833 1 1 6.4e-08 2.1e-08 5.4e-02 88 CTTNBP2
2 8 27205777 27720371 1 1 3.9e-09 1.2e-08 1.0e-02 80 CLU
3 8 91282507 92689456 1 1 1.8e-07 2.3e-06 1.8e-03 56 RP11-122A3.2
4 9 126946822 129422783 8 2 2.8e-10 2.7e-08 9.1e-01 100 MAPKAP1 PRPS1P2
5 9 135521303 136922700 2 1 7.5e-09 1.7e-23 7.5e-19 21 SURF1
6 10 103550604 105647095 4 2 3.8e-08 1.1e-07 1.8e-01 94 C10orf32 NT5C2
7 12 120242845 121660787 1 1 2.3e-07 1.6e-04 5.1e-01 97 COQ5
8 14 103483881 105007585 2 1 6.7e-08 5.7e-07 6.2e-02 86 PPP1R13B
9 15 46780520 48764942 1 1 4.1e-08 6.1e-08 4.5e-04 58 SEMA6D
10 17 78843139 79380547 1 1 6.9e-08 1.8e-07 1.0e+00 100 AATK
11 19 41034912 41537868 1 1 9.3e-09 1.5e-06 1.7e-04 39 RAB4B
12 20 61576647 62912463 5 1 2.0e-08 7.3e-08 3.4e-01 97 RTEL1
13 22 41181586 42907619 8 1 8.4e-10 3.3e-08 2.1e-01 95 PHF5A

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder (2018) 1.67 1 0 0.0 0.00 1.0e+00 PPP1R13B
Bipolar Disorder or Schizophrenia 2.70 2 1 2.2 0.00 1.0e+00 C10orf32 PPP1R13B
Depressed Affect (Nagel 2018) 2.40 3 1 2.2 0.00 1.0e+00 AATK CTTNBP2 PHF5A
Depression (Nagel 2018) 2.42 1 0 0.0 0.00 1.0e+00 AATK
Intelligence (Savage-Jansen 2018) 1.19 2 0 0.0 0.00 1.0e+00 AATK PPP1R13B
Neuroticism (Nagel 2018) 3.97 5 1 2.2 -0.34 5.8e-01 AATK C10orf32 CTTNBP2 PHF5A PRPS1P2
Schizophrenia (2018) 2.83 3 1 2.2 0.00 1.0e+00 C10orf32 CLU PPP1R13B
Schizophrenia vs Biploar Disorder 1.58 1 0 0.0 0.00 1.0e+00 CLU
Worry (Nagel 2018) 4.08 4 2 4.4 -0.18 8.2e-01 AATK C10orf32 NT5C2 PRPS1P2
Alzheimer’s Disease (including proxy) 1.73 1 0 0.0 0.00 1.0e+00 CLU
Crohns Disease (2017) 3.07 2 1 2.2 0.00 1.0e+00 PHF5A RTEL1
Irritable Bowel Disease (IBD) 3.18 1 1 2.2 0.00 1.0e+00 RTEL1
Ulcerative Colitis (UC) 2.24 1 1 2.2 0.00 1.0e+00 RTEL1
Major Depression (MDD) 3.49 1 0 0.0 0.00 1.0e+00 CTTNBP2
Verbal and Numeric Reasoning (VNR) 1.33 1 0 0.0 0.00 1.0e+00 PPP1R13B
Breast Cancer 0.85 1 0 0.0 0.00 1.0e+00 CLU
Prostate Cancer 4.60 1 1 2.2 0.00 1.0e+00 RTEL1
Coronary Artery Disease (CAD) 1.53 1 0 0.0 0.00 1.0e+00 C10orf32
Crohns Disease (2012) 2.97 1 1 2.2 0.00 1.0e+00 RTEL1
Neuroticism (2016) 2.59 1 0 0.0 0.00 1.0e+00 AATK
Schizophrenia (2014) 2.68 3 1 2.2 0.00 1.0e+00 C10orf32 CLU PPP1R13B
Ulcerative Colitis 2.25 1 1 2.2 0.00 1.0e+00 RTEL1
Blood Eosinophil Count 1.45 4 1 2.2 0.24 7.6e-01 AATK PHF5A PPP1R13B SURF1
Blood Platelet Count 0.99 4 2 4.4 0.96 3.9e-02 C10orf32 NT5C2 PHF5A RTEL1
Blood Red Count 0.94 4 2 4.4 0.99 9.6e-03 MAPKAP1 PPP1R13B RTEL1 SURF1
Blood White Count 2.17 7 4 8.9 0.99 4.7e-05 AATK C10orf32 NT5C2 PPP1R13B RTEL1 SEMA6D SURF1
Heel T-Score 1.17 3 1 2.2 0.00 1.0e+00 PHF5A PPP1R13B RTEL1
BMI 1.72 5 1 2.2 0.73 1.6e-01 C10orf32 MAPKAP1 PPP1R13B RAB4B RP11-122A3.2
Height 1.82 12 7 15.6 -0.36 2.6e-01 AATK C10orf32 CLU COQ5 CTTNBP2 MAPKAP1 NT5C2 PHF5A PPP1R13B PRPS1P2 RP11-122A3.2 RTEL1
Waist Hip Ratio (WHR) 1.46 3 0 0.0 0.00 1.0e+00 MAPKAP1 PRPS1P2 SEMA6D
Systolic Blood Pressure 2.24 5 2 4.4 -0.69 2.0e-01 C10orf32 COQ5 MAPKAP1 RP11-122A3.2 RTEL1
Smoking Status 18.02 14 9 20.0 0.96 3.5e-08 AATK C10orf32 CLU COQ5 CTTNBP2 MAPKAP1 NT5C2 PHF5A PPP1R13B PRPS1P2 RP11-122A3.2 RTEL1 SEMA6D SURF1
Allergy or Eczema 2.91 3 2 4.4 0.00 1.0e+00 NT5C2 PHF5A RTEL1
Cardiovascular Disease 1.14 1 0 0.0 0.00 1.0e+00 MAPKAP1
Hypothyroidism (self reported) 1.10 1 0 0.0 0.00 1.0e+00 PHF5A
Respiratory disease 2.65 2 1 2.2 0.00 1.0e+00 PHF5A RTEL1
Type 2 Diabetes (T2D) (2018) 2.31 1 0 0.0 0.00 1.0e+00 RTEL1
Lung FEV1/FVC ratio 1.18 3 0 0.0 0.00 1.0e+00 C10orf32 CTTNBP2 RAB4B
Lung FVC 2.46 3 1 2.2 0.00 1.0e+00 CTTNBP2 PRPS1P2 RTEL1
Neuroticism 3.66 5 1 2.2 -0.22 7.2e-01 AATK C10orf32 CTTNBP2 PHF5A PRPS1P2
Chronotype (morning person) 1.40 1 0 0.0 0.00 1.0e+00 PHF5A
Hair Pigment 0.23 3 1 2.2 0.00 1.0e+00 PHF5A PPP1R13B RTEL1
Tanning 0.33 2 0 0.0 0.00 1.0e+00 C10orf32 MAPKAP1
Hand grip strength (left) 2.41 4 0 0.0 -0.07 9.3e-01 C10orf32 MAPKAP1 NT5C2 PRPS1P2
Sensitivity / hurt feelings 3.43 3 0 0.0 0.00 1.0e+00 AATK MAPKAP1 PRPS1P2
Frequency of depressed mood in last 2 weeks 2.48 1 0 0.0 0.00 1.0e+00 AATK
Systolic blood pressure, automated reading 2.02 3 0 0.0 0.00 1.0e+00 C10orf32 MAPKAP1 RTEL1
Medication for hormone replacement therapy 1.19 1 0 0.0 0.00 1.0e+00 RAB4B
Vitamin and mineral supplements 1.64 1 0 0.0 0.00 1.0e+00 NT5C2
Diabetes (mother) 2.08 1 0 0.0 0.00 1.0e+00 COQ5
Pack years adult smoking proportion 6.26 5 1 2.2 0.47 4.3e-01 MAPKAP1 PPP1R13B RAB4B SEMA6D SURF1
Impedance of leg (right) 1.36 5 0 0.0 0.48 4.1e-01 C10orf32 PPP1R13B PRPS1P2 RTEL1 SEMA6D
Leg fat-free mass (left) 1.49 2 1 2.2 0.00 1.0e+00 C10orf32 PRPS1P2
Trunk fat percentage 1.75 4 1 2.2 -0.12 8.8e-01 PHF5A RP11-122A3.2 RTEL1 SEMA6D
Hand grip strength (right) 2.50 4 1 2.2 -0.16 8.4e-01 C10orf32 MAPKAP1 NT5C2 PRPS1P2
Townsend deprivation index at recruitment 4.06 4 0 0.0 0.98 1.7e-02 C10orf32 CTTNBP2 MAPKAP1 PRPS1P2
Maternal smoking around birth 6.30 4 0 0.0 0.99 1.3e-02 C10orf32 NT5C2 PHF5A PPP1R13B
Fed-up feelings 2.26 3 0 0.0 0.00 1.0e+00 AATK CTTNBP2 PHF5A
Frequency of unenthusiasm / disinterest in last 2 weeks 3.13 2 0 0.0 0.00 1.0e+00 AATK CTTNBP2
Age when periods started (menarche) 1.23 1 0 0.0 0.00 1.0e+00 PRPS1P2
High blood pressure 0.96 1 0 0.0 0.00 1.0e+00 MAPKAP1
Hayfever, allergic rhinitis or eczema 2.75 3 2 4.4 0.00 1.0e+00 NT5C2 PHF5A RTEL1
Sitting height 1.19 6 0 0.0 -0.39 4.4e-01 AATK C10orf32 MAPKAP1 PRPS1P2 RP11-122A3.2 SURF1
Body mass index (BMI) 1.63 3 0 0.0 0.00 1.0e+00 C10orf32 PPP1R13B RP11-122A3.2
Impedance of leg (left) 1.36 4 0 0.0 0.63 3.7e-01 PPP1R13B PRPS1P2 RTEL1 SEMA6D
Leg predicted mass (left) 1.48 2 1 2.2 0.00 1.0e+00 C10orf32 PRPS1P2
Trunk fat mass 1.68 4 0 0.0 -0.34 6.6e-01 C10orf32 PHF5A RTEL1 SEMA6D
Waist circumference 1.94 4 0 0.0 0.99 7.8e-03 C10orf32 PPP1R13B RP11-122A3.2 RTEL1
Number of incorrect matches in round 2.61 2 0 0.0 0.00 1.0e+00 C10orf32 NT5C2
Past tobacco smoking 8.37 6 3 6.7 -0.76 7.8e-02 C10orf32 CLU CTTNBP2 NT5C2 PRPS1P2 RAB4B
Alcohol usually taken with meals 4.07 3 0 0.0 0.00 1.0e+00 CLU CTTNBP2 NT5C2
Nervous feelings 3.31 3 1 2.2 0.00 1.0e+00 AATK C10orf32 PRPS1P2
Frequency of tenseness / restlessness in last 2 weeks 2.10 1 0 0.0 0.00 1.0e+00 AATK
Forced vital capacity (FVC) 2.03 2 2 4.4 0.00 1.0e+00 PRPS1P2 RTEL1
Qualifications: None of the above 2.16 1 0 0.0 0.00 1.0e+00 SEMA6D
Financial difficulties in last 2 years 3.33 1 0 0.0 0.00 1.0e+00 PPP1R13B
Mouth/teeth dental problems 3.28 2 0 0.0 0.00 1.0e+00 AATK PRPS1P2
Allergy 3.07 2 2 4.4 0.00 1.0e+00 PHF5A RTEL1
Fluid intelligence score 1.56 2 0 0.0 0.00 1.0e+00 AATK PPP1R13B
Neuroticism score 3.32 4 1 2.2 -0.55 4.5e-01 AATK CTTNBP2 PHF5A PRPS1P2
Weight 1.61 3 1 2.2 0.00 1.0e+00 C10orf32 NT5C2 PHF5A
Impedance of arm (right) 1.39 3 1 2.2 0.00 1.0e+00 C10orf32 PHF5A RAB4B
Arm fat percentage (right) 1.97 5 0 0.0 0.13 8.4e-01 MAPKAP1 PHF5A PPP1R13B RP11-122A3.2 SEMA6D
Trunk fat-free mass 1.52 4 2 4.4 0.06 9.4e-01 C10orf32 MAPKAP1 NT5C2 PRPS1P2
Hip circumference 1.86 4 1 2.2 0.23 7.7e-01 C10orf32 PPP1R13B RTEL1 SEMA6D
Alcohol intake versus 10 years previously 3.66 3 1 2.2 0.00 1.0e+00 CLU CTTNBP2 NT5C2
Father's age at death 2.07 1 0 0.0 0.00 1.0e+00 CLU
Worrier / anxious feelings 4.09 3 1 2.2 0.00 1.0e+00 C10orf32 NT5C2 PHF5A
Frequency of tiredness / lethargy in last 2 weeks 3.32 4 0 0.0 -0.51 4.9e-01 AATK PHF5A PPP1R13B PRPS1P2
Forced expiratory volume in 1-second (FEV1) 2.24 3 2 4.4 0.00 1.0e+00 CTTNBP2 PRPS1P2 RTEL1
Pulse rate 2.19 1 0 0.0 0.00 1.0e+00 MAPKAP1
Qualifications: A levels/AS levels or equivalent 2.04 2 0 0.0 0.00 1.0e+00 CTTNBP2 SEMA6D
Mouth/teeth dental problems: Dentures 2.86 1 0 0.0 0.00 1.0e+00 CLU
Asthma 1.74 2 1 2.2 0.00 1.0e+00 PHF5A RTEL1
Lung cancer (father) 2.68 1 0 0.0 0.00 1.0e+00 CLU
Forced expiratory volume in 1-second (FEV1), Best measure 1.61 2 0 0.0 0.00 1.0e+00 PRPS1P2 RTEL1
Pulse wave Arterial Stiffness index 1.87 1 0 0.0 0.00 1.0e+00 C10orf32
Impedance of arm (left) 1.49 2 1 2.2 0.00 1.0e+00 C10orf32 PHF5A
Arm fat mass (right) 1.71 5 0 0.0 0.13 8.3e-01 C10orf32 PHF5A PPP1R13B RP11-122A3.2 SEMA6D
Trunk predicted mass 1.53 4 2 4.4 0.06 9.4e-01 C10orf32 MAPKAP1 NT5C2 PRPS1P2
Standing height 1.59 7 3 6.7 -0.70 7.7e-02 AATK C10orf32 COQ5 MAPKAP1 PHF5A PRPS1P2 RP11-122A3.2
Tense / 'highly strung' 2.60 2 0 0.0 0.00 1.0e+00 AATK PHF5A
Seen doctor (GP) for nerves, anxiety, tension or depression 3.01 3 0 0.0 0.00 1.0e+00 AATK CTTNBP2 PRPS1P2
Birth weight of first child 1.95 1 0 0.0 0.00 1.0e+00 C10orf32
Peak expiratory flow (PEF) 2.50 3 1 2.2 0.00 1.0e+00 C10orf32 CTTNBP2 PRPS1P2
Medication for cholesterol, blood pressure or diabetes 0.84 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Amlodipine 1.84 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Ventolin 100micrograms inhaler 2.40 1 0 0.0 0.00 1.0e+00 PHF5A
Birth weight 1.24 1 0 0.0 0.00 1.0e+00 C10orf32
Forced vital capacity (FVC), Best measure 1.48 2 1 2.2 0.00 1.0e+00 PRPS1P2 RTEL1
Body fat percentage 1.87 4 0 0.0 0.52 4.8e-01 MAPKAP1 PHF5A RP11-122A3.2 RTEL1
Leg fat percentage (right) 1.96 3 0 0.0 0.00 1.0e+00 MAPKAP1 RP11-122A3.2 RTEL1
Arm fat-free mass (right) 1.52 3 1 2.2 0.00 1.0e+00 C10orf32 NT5C2 PRPS1P2
Exposure to tobacco smoke outside home 4.38 2 0 0.0 0.00 1.0e+00 C10orf32 CTTNBP2
Comparative body size at age 10 1.31 1 0 0.0 0.00 1.0e+00 PHF5A
Worry too long after embarrassment 2.14 2 0 0.0 0.00 1.0e+00 CTTNBP2 PRPS1P2
Seen a psychiatrist for nerves, anxiety, tension or depression 2.75 2 0 0.0 0.00 1.0e+00 CTTNBP2 PRPS1P2
Wheeze or whistling in the chest in last year 2.89 1 0 0.0 0.00 1.0e+00 RTEL1
Pulse wave peak to peak time 1.94 1 0 0.0 0.00 1.0e+00 C10orf32
Qualifications: College or University degree 2.89 6 1 2.2 -0.99 3.2e-04 C10orf32 CTTNBP2 NT5C2 PRPS1P2 RTEL1 SEMA6D
Medication for pain relief, constipation, heartburn 2.07 1 0 0.0 0.00 1.0e+00 PRPS1P2
Medication: Blood pressure 0.82 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Allopurinol 1.53 1 0 0.0 0.00 1.0e+00 RAB4B
Whole body fat mass 1.84 5 0 0.0 0.17 7.8e-01 C10orf32 PHF5A RP11-122A3.2 RTEL1 SEMA6D
Leg fat mass (right) 1.85 3 0 0.0 0.00 1.0e+00 C10orf32 RP11-122A3.2 RTEL1
Arm predicted mass (right) 1.56 3 1 2.2 0.00 1.0e+00 C10orf32 NT5C2 PRPS1P2
Pulse rate, automated reading 3.48 3 1 2.2 0.00 1.0e+00 MAPKAP1 RP11-122A3.2 RTEL1
Alcohol intake frequency. 1.83 1 0 0.0 0.00 1.0e+00 PHF5A
Comparative height size at age 10 1.17 3 1 2.2 0.00 1.0e+00 C10orf32 COQ5 MAPKAP1
Suffer from 'nerves' 2.43 2 0 0.0 0.00 1.0e+00 AATK C10orf32
Overall health rating 3.06 3 0 0.0 0.00 1.0e+00 AATK MAPKAP1 PRPS1P2
Commuting to job workplace: Car/motor vehicle 1.74 1 0 0.0 0.00 1.0e+00 RP11-122A3.2
Illness, injury, bereavement, stress in last 2 years 2.13 1 0 0.0 0.00 1.0e+00 CTTNBP2
Hypertension (Self-reported) 0.94 1 0 0.0 0.00 1.0e+00 MAPKAP1
Smoking status: Previous 4.60 3 0 0.0 0.00 1.0e+00 C10orf32 NT5C2 RAB4B
Forced expiratory volume in 1-second (FEV1), predicted 1.50 1 0 0.0 0.00 1.0e+00 C10orf32
Whole body fat-free mass 1.48 3 2 4.4 0.00 1.0e+00 C10orf32 NT5C2 PRPS1P2
Leg fat-free mass (right) 1.51 2 1 2.2 0.00 1.0e+00 C10orf32 PRPS1P2
Arm fat percentage (left) 1.92 5 0 0.0 0.07 9.1e-01 MAPKAP1 PHF5A PPP1R13B RP11-122A3.2 SEMA6D
Mood swings 2.55 2 0 0.0 0.00 1.0e+00 CTTNBP2 PHF5A
Long-standing illness, disability or infirmity 2.56 1 0 0.0 0.00 1.0e+00 CLU
Ever had bowel cancer screening 2.24 1 0 0.0 0.00 1.0e+00 SURF1
Asthma (self-reported) 1.81 2 1 2.2 0.00 1.0e+00 PHF5A RTEL1
Osteoarthritis (self-reported) 2.30 1 0 0.0 0.00 1.0e+00 MAPKAP1
Smoking status: Current 17.76 15 9 20.0 1.00 3.8e-17 AATK C10orf32 CLU COQ5 CTTNBP2 MAPKAP1 NT5C2 PHF5A PPP1R13B PRPS1P2 RAB4B RP11-122A3.2 RTEL1 SEMA6D SURF1
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.02 2 1 2.2 0.00 1.0e+00 PRPS1P2 RTEL1
Whole body water mass 1.47 3 2 4.4 0.00 1.0e+00 C10orf32 NT5C2 PRPS1P2
Leg predicted mass (right) 1.49 2 1 2.2 0.00 1.0e+00 C10orf32 PRPS1P2
Arm fat mass (left) 1.70 5 0 0.0 0.11 8.5e-01 C10orf32 PHF5A PPP1R13B RP11-122A3.2 SEMA6D
Number of self-reported non-cancer illnesses 2.56 2 0 0.0 0.00 1.0e+00 PHF5A RTEL1
Miserableness 1.84 2 0 0.0 0.00 1.0e+00 AATK CTTNBP2
Guilty feelings 2.40 1 0 0.0 0.00 1.0e+00 AATK
Mother's age at death 2.64 1 0 0.0 0.00 1.0e+00 MAPKAP1
High cholesterol (Self-reported) 1.33 1 0 0.0 0.00 1.0e+00 SURF1
Ever smoked 8.38 5 4 8.9 0.98 3.9e-03 AATK C10orf32 CTTNBP2 NT5C2 PRPS1P2
Basal metabolic rate 1.45 3 1 2.2 0.00 1.0e+00 C10orf32 NT5C2 PRPS1P2
Leg fat percentage (left) 2.17 3 1 2.2 0.00 1.0e+00 MAPKAP1 RP11-122A3.2 RTEL1
Arm fat-free mass (left) 1.49 3 1 2.2 0.00 1.0e+00 C10orf32 NT5C2 PRPS1P2
Irritability 2.59 1 0 0.0 0.00 1.0e+00 PHF5A
Risk taking 3.08 2 0 0.0 0.00 1.0e+00 NT5C2 PPP1R13B
Fractured/broken bones in last 5 years 1.83 1 0 0.0 0.00 1.0e+00 CTTNBP2
Diastolic blood pressure, automated reading 2.21 3 1 2.2 0.00 1.0e+00 MAPKAP1 NT5C2 RTEL1
Vascular/heart problems diagnosed by doctor 1.09 2 0 0.0 0.00 1.0e+00 MAPKAP1 NT5C2
Pain experienced in last month 1.79 1 0 0.0 0.00 1.0e+00 PRPS1P2
Basal cell carcinoma (self-reported) 1.26 1 0 0.0 0.00 1.0e+00 PHF5A
Pack years of smoking 6.06 4 1 2.2 0.41 5.9e-01 PPP1R13B RAB4B SEMA6D SURF1
Impedance of whole body 1.42 4 1 2.2 0.55 4.5e-01 C10orf32 PHF5A PPP1R13B PRPS1P2
Leg fat mass (left) 1.95 3 0 0.0 0.00 1.0e+00 C10orf32 RP11-122A3.2 RTEL1
Arm predicted mass (left) 1.47 3 1 2.2 0.00 1.0e+00 C10orf32 NT5C2 PRPS1P2

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 1 0.029 1.7
GTEx Adipose Visceral Omentum 1 0.049 1.7
GTEx Adrenal Gland 0 0.000 1.7
GTEx Artery Aorta 1 0.034 1.7
GTEx Artery Coronary 0 0.000 1.6
GTEx Artery Tibial 0 0.000 1.6
GTEx Brain Caudate basal ganglia 0 0.000 1.7
GTEx Brain Cerebellar Hemisphere 2 0.134 1.7
GTEx Brain Cerebellum 1 0.050 1.7
GTEx Brain Cortex 0 0.000 1.8
GTEx Brain Frontal Cortex BA9 0 0.000 1.7
GTEx Brain Hippocampus 0 0.000 1.6
GTEx Brain Hypothalamus 0 0.000 1.6
GTEx Brain Nucleus accumbens basal ganglia 0 0.000 1.7
GTEx Brain Putamen basal ganglia 0 0.000 1.6
GTEx Breast Mammary Tissue 0 0.000 1.7
GTEx Breast Mammary Tissue (Male) 1 0.084 1.6
GTEx Breast Mammary Tissue (Female) 0 0.000 1.6
GTEx Cells EBV-transformed lymphocytes 1 0.070 1.6
GTEx Cells Transformed fibroblasts 2 0.048 1.7
GTEx Colon Sigmoid 0 0.000 1.7
GTEx Colon Transverse 0 0.000 1.6
GTEx Esophagus Gastroesophageal Junction 0 0.000 1.7
GTEx Esophagus Mucosa 0 0.000 1.6
GTEx Esophagus Muscularis 0 0.000 1.7
GTEx Heart Atrial Appendage 0 0.000 1.7
GTEx Heart Left Ventricle 0 0.000 1.7
GTEx Liver 1 0.139 1.6
GTEx Lung 0 0.000 1.6
GTEx Muscle Skeletal 1 0.035 1.7
GTEx Nerve Tibial 1 0.023 1.6
GTEx Ovary 1 0.110 1.6
GTEx Pancreas 0 0.000 1.8
GTEx Pituitary 0 0.000 1.6
GTEx Prostate 0 0.000 1.7
GTEx Skin Not Sun Exposed Suprapubic 1 0.041 1.7
GTEx Skin Sun Exposed Lower leg 3 0.082 1.6
GTEx Small Intestine Terminal Ileum 1 0.217 1.7
GTEx Spleen 1 0.071 1.7
GTEx Stomach 1 0.069 1.8
GTEx Testis 1 0.032 1.7
GTEx Thyroid 2 0.050 1.7
GTEx Uterus 0 0.000 1.7
GTEx Vagina 0 0.000 1.5
GTEx Whole Blood 1 0.050 1.7
METSIM Adipose 0 0.000 1.6
NTR Blood 2 0.083 1.6
ROSMAP Brain Pre-frontal Cortex 2 0.046 1.7
YFS Blood 2 0.043 1.6
CommonMind Brain Pre-frontal Cortex 3 0.056 1.6
The Cancer Genome Atlas Bladder Urothelial Carcinoma 1 0.060 1.6
The Cancer Genome Atlas Breast Invasive Carcinoma 3 0.068 1.6
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Colon Adenocarcinoma 2 0.097 1.7
The Cancer Genome Atlas Esophageal Carcinoma 0 0.000 1.7
The Cancer Genome Atlas Glioblastoma Multiforme 0 0.000 1.6
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 1 0.037 1.7
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 2 0.049 1.6
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 2 0.098 1.6
The Cancer Genome Atlas Brain Lower Grade Glioma 1 0.023 1.6
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 3 0.120 1.6
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 2 0.126 1.7
The Cancer Genome Atlas Pancreatic Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 1 0.075 1.7
The Cancer Genome Atlas Prostate Adenocarcinoma 1 0.022 1.6
The Cancer Genome Atlas Rectum Adenocarcinoma 1 0.145 1.7
The Cancer Genome Atlas Soft Tissue Sarcoma 0 0.000 1.6
The Cancer Genome Atlas Skin Cutaneous Melanoma 0 0.000 1.6
The Cancer Genome Atlas Stomach Adenocarcinoma 0 0.000 1.7
The Cancer Genome Atlas Testicular Germ Cell Tumors 2 0.156 1.6
The Cancer Genome Atlas Thyroid Carcinoma 2 0.039 1.6
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 0 0.000 1.7